Abstract:Abstract Introduction The 27-hydroxycholesterol(27-OH) has been proposed as a factor mediating the risk of Alzheimer's disease(AD) through oxidative cholesterol metabolism associated with cognitive impairment. Meanwhile, circadian disturbance has been implicated in accelerated aging and incident dementia, mediating metabolic dysregulation, which may lead to neurodegenerative diseases like AD. However, the relationship between circadian rhythm and cholesterol metabolism in MCI is poorly understood. We aimed to compare circadian parameters between amnestic MCI(aMCI) patients and normal controls(NC), and to examine whether changes in circadian parameters can be related with 27-OH levels. Methods Participants over 50 years were recruited from the Memory Clinic at Kangwon National University Hospital, and two public Dementia Care Centers. The diagnosis of aMCI was made according to Petersen’s criteria. Actigraphy monitoring was conducted at home for five days. Nonparametric variables including the inter-daily stability(IS), intra-daily variability(IV) and relative amplitude(RA) were calculated for rest-activity rhythm(RAR) and light exposure rhythm(LER), respectively. DLMO was determined from five hourly saliva samples obtained before sleep onset. The 27-OH levels were measured using high performance liquid chromatography/mass spectrometry(HPLC/MS). Eighteen aMCI patients(76.6 ±6.1 years) and 21 NCs(70.4±6.7years) were finally analyzed. Generalized linear models(GLMs) were used to assess the main effects of circadian parameters on 27-OH levels and their interactions with group. Results There were no significant differences in the RAR and LER variables(IV, IS and RA), and the DLMO between the aMCI and NC groups. In GLMs, significant main effects of RA in RAR and IV in LER on 27-OH levels were shown (β = -461.43, p=.036; β = -149.35, p=.001, respectively). There was no difference in the effects of circadian parameters on 27-OH levels between the aMCI and NC groups (p>.05). Conclusion In our study, a strong 24-hour activity rhythm was associated with lower 27-OH levels, indicating less cholesterol metabolic dysfunction. It suggests that changes in circadian rhythm may affect cholesterol metabolism in preclinical AD patients. Support (if any) Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Science and ICT(2020R1F1A1050416);Learning & Academic research institution for Master’s·PhD students, and Postdocs(LAMP) Program of the National Research Foundation of Korea(NRF) grant funded by the Ministry of Education(No. RS-2023-00285353).

Changes in 24(S)-Hydroxycholesterol Are Associated with Cognitive Performance in Early Huntington's Disease: Data from the TRACK and ENROLL HD Cohorts

Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls And Predict Early Alzheimer'S Disease Via Untargeted Lipidomics Analysis

High-density lipoprotein over midlife and future cognition in women: The SWAN HDL ancillary study

Altered Cholesterol Homeostasis in Huntington's Disease

27-hydroxycholesterol promotes oligodendrocyte maturation: Implications for hypercholesterolemia-associated brain white matter changes

Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats

24S-Hydroxycholesterol Induces Inflammatory Gene Expression in Primary Human Neural Cells

Interaction Between DHCR24 and Hsa_circ_0015335 Facilitates Cognitive Impairment in Cerebral Small Vessel Disease Patients

1009 Association of Circadian Rhythm with 27-Hydroxycholesterol in Amnestic Mild Cognitive Impairment (aMCI) Patients

Cholesterol profiling reveals 7β‐hydroxycholesterol as a pathologically relevant peripheral biomarker of Alzheimer's disease

Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington's Disease

Connecting the Dots Between Hypercholesterolemia and Alzheimer's Disease: A Potential Mechanism Based on 27-Hydroxycholesterol

Increased Plasma Level Of 24s-Hydroxycholesterol And Polymorphism Of Cyp46a1 Snp (Rs754203) Are Associated With Mild Cognitive Impairment In Patients With Type 2 Diabetes

Connecting the Dots Between Hypercholesterolemia and Alzheimer’s Disease: A Potential Mechanism Based on 27-Hydroxycholesterol

Resting-state Fmri Reveals Potential Neural Correlates of Impaired Cognition in Huntington's Disease.

Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme Cyp46a1 on Behavior and Hippocampal Transcription in Mouse

Changes in Cholesterol Metabolism in Peripheral Cells of Alzheimer Disease Patients and Their Relatives

Plasma oxysterols are associated with serum lipids and dementia risk in older women

27-Hydroxycholesterol Drives the Spread of -Synuclein Pathology in Parkinson's Disease

Tissue-Specific Oxysterols As Predictors of Antidepressant (escitalopram) Treatment Response in Patients with Major Depressive Disorder

Effects of CYP46A1 Inhibition on Long-Term-Depression in Hippocampal Slices ex vivo and 24S-Hydroxycholesterol Levels in Mice in vivo